[Federal Register Volume 72, Number 102 (Tuesday, May 29, 2007)]
[Notices]
[Page 29501]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-10246]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Enhanced Surveillance for New Vaccine Preventable 
Disease, Funding Opportunity

    Announcement (FOA) IP07-001, Effectiveness of an Intervention to 
Promote Comprehensive Vaccination Programs in the Obstetrician-
Gynecologist Setting, FOA IP07-008, and Impact of New Adolescent 
Vaccines on the Delivery of Recommended Clinical Preventive Services, 
FOA IP07-009
    In accordance with section 10(a)(2) of the Federal Advisory
    Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting of the aforementioned Special 
Emphasis Panel.

    Time and Date: 12 p.m.-4 p.m., June 15, 2007 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of research grant applications in 
response to FOA IP07-001, ``Enhanced Surveillance for New Vaccine 
Preventable Disease'', FOA IP07-008 ``Effectiveness of an 
Intervention to Promote Comprehensive Vaccination Programs in the 
Obstetrician-Gynecologist Setting'', and FOA IP07-009 ``Impact of 
New Adolescent Vaccines on the Delivery of Recommended Clinical 
Preventive Services''.
    Contact Person for More Information: Trudy Messmer, PhD, 
Designated Federal Official, 1600 Clifton Road, Mailstop C-19, 
Atlanta, GA 30333, telephone (404) 639-2176.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 22, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E7-10246 Filed 5-25-07; 8:45 am]
BILLING CODE 4163-18-P